158 related articles for article (PubMed ID: 37578576)
21. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
[TBL] [Abstract][Full Text] [Related]
22. Distinct radiological features of lymphoepithelioma-like intrahepatic cholangiocarcinoma: comparison with classical intrahepatic cholangiocarcinoma.
Liu LH; Wang ML; Jiang F; Chen LL; Ji Y; Zeng MS
Abdom Radiol (NY); 2023 Jun; 48(6):2038-2048. PubMed ID: 37004556
[TBL] [Abstract][Full Text] [Related]
23. Preoperative evaluation of MRI features and inflammatory biomarkers in predicting microvascular invasion of combined hepatocellular cholangiocarcinoma.
Zhang J; Dong W; Liu W; Fu J; Liao T; Li Y; Huo L; Jia N
Abdom Radiol (NY); 2024 Mar; 49(3):710-721. PubMed ID: 38112787
[TBL] [Abstract][Full Text] [Related]
24. MRI appearance of combined hepatocellular cholangiocarcinoma.
Billet N; Grégory J; Ronot M
Diagn Interv Imaging; 2022 Dec; 103(12):625-626. PubMed ID: 36243674
[No Abstract] [Full Text] [Related]
25. Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using Gd-EOB-DTPA-enhanced magnetic resonance imaging combined with serum markers in at-risk patients with hepatitis B virus.
Han D; Li Y; He X; Zhang J; Zhou Y; Zhang J; Zhang L
Quant Imaging Med Surg; 2023 Oct; 13(10):7156-7169. PubMed ID: 37869332
[TBL] [Abstract][Full Text] [Related]
26. Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis.
Zhou C; Wang Y; Ma L; Qian X; Yang C; Zeng M
Eur Radiol; 2022 Jan; 32(1):78-88. PubMed ID: 34279688
[TBL] [Abstract][Full Text] [Related]
27. Differentiation of Intrahepatic Cholangiocellular Carcinoma from Hepatocellular Carcinoma in the Cirrhotic Liver Using Contrast-enhanced MR Imaging.
Wengert GJ; Baltzer PAT; Bickel H; Thurner P; Breitenseher J; Lazar M; Pones M; Peck-Radosavljevic M; Hucke F; Ba-Ssalamah A
Acad Radiol; 2017 Dec; 24(12):1491-1500. PubMed ID: 28756085
[TBL] [Abstract][Full Text] [Related]
28. Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers.
Wakizaka K; Yokoo H; Kamiyama T; Ohira M; Kato K; Fujii Y; Sugiyama K; Okada N; Ohata T; Nagatsu A; Shimada S; Orimo T; Kamachi H; Taketomi A
J Gastroenterol Hepatol; 2019 Jun; 34(6):1074-1080. PubMed ID: 30462849
[TBL] [Abstract][Full Text] [Related]
29. Gadoxetic acid disodium-enhanced MR imaging of cholangiolocellular carcinoma of the liver: imaging characteristics and histopathological correlations.
Haradome H; Unno T; Morisaka H; Toda Y; Kwee TC; Kondo H; Sano K; Ichikawa T; Kondo F; Sugitani M; Takayama T
Eur Radiol; 2017 Nov; 27(11):4461-4471. PubMed ID: 28439650
[TBL] [Abstract][Full Text] [Related]
30. DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.
Zhou Y; Zhou G; Zhang J; Xu C; Zhu F; Xu P
Eur Radiol; 2022 Jul; 32(7):5004-5015. PubMed ID: 35128572
[TBL] [Abstract][Full Text] [Related]
31. Optimizing CT and MRI criteria for differentiating intrahepatic mass-forming cholangiocarcinoma and hepatocellular carcinoma.
Wu H; Liang Y; Wang Z; Tan C; Yang R; Wei X; Jiang X
Acta Radiol; 2023 Mar; 64(3):926-935. PubMed ID: 35898164
[TBL] [Abstract][Full Text] [Related]
32. Targetoid appearance on T2-weighted imaging and signs of tumor vascular involvement: diagnostic value for differentiating HCC from other primary liver carcinomas.
Cannella R; Fraum TJ; Ludwig DR; Borhani AA; Tsung A; Furlan A; Fowler KJ
Eur Radiol; 2021 Sep; 31(9):6868-6878. PubMed ID: 33590319
[TBL] [Abstract][Full Text] [Related]
33. Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI.
Hwang J; Kim YK; Park MJ; Lee MH; Kim SH; Lee WJ; Rhim HC
J Magn Reson Imaging; 2012 Oct; 36(4):881-9. PubMed ID: 22730271
[TBL] [Abstract][Full Text] [Related]
34. Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection.
Chi CT; Chau GY; Lee RC; Chen YY; Lei HJ; Hou MC; Chao Y; Huang YH
J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):125-133. PubMed ID: 30876788
[TBL] [Abstract][Full Text] [Related]
35. Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?
Huang JY; Li JW; Ling WW; Li T; Luo Y; Liu JB; Lu Q
World J Gastroenterol; 2020 Jul; 26(27):3938-3951. PubMed ID: 32774068
[TBL] [Abstract][Full Text] [Related]
36. Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis.
Vidili G; Arru M; Solinas G; Calvisi DF; Meloni P; Sauchella A; Turilli D; Fabio C; Cossu A; Madeddu G; Babudieri S; Zocco MA; Iannetti G; Di Lembo E; Delitala AP; Manetti R
World J Gastroenterol; 2022 Jul; 28(27):3488-3502. PubMed ID: 36158272
[TBL] [Abstract][Full Text] [Related]
37. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.
Sammon J; Fischer S; Menezes R; Hosseini-Nik H; Lewis S; Taouli B; Jhaveri K
Cancer Imaging; 2018 Feb; 18(1):8. PubMed ID: 29486800
[TBL] [Abstract][Full Text] [Related]
38. Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014.
Horvat N; Nikolovski I; Long N; Gerst S; Zheng J; Pak LM; Simpson A; Zheng J; Capanu M; Jarnagin WR; Mannelli L; Do RKG
Abdom Radiol (NY); 2018 Jan; 43(1):169-178. PubMed ID: 28765978
[TBL] [Abstract][Full Text] [Related]
39. Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Yang J; Zhang YH; Li JW; Shi YY; Huang JY; Luo Y; Liu JB; Lu Q
World J Gastroenterol; 2020 Dec; 26(46):7325-7337. PubMed ID: 33362387
[TBL] [Abstract][Full Text] [Related]
40. Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (≥5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI.
Hwang J; Kim YK; Min JH; Choi SY; Jeong WK; Hong SS; Kim HJ; Ahn S; Ahn HS
Eur Radiol; 2017 Nov; 27(11):4581-4590. PubMed ID: 28500365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
